A phosphatidylethanol, or PEth, blood result can support that ethanol exposure occurred during a preceding period, but it does not identify an exact drinking date, number of drinks, blood alcohol concentration, or degree of impairment. A defensible interpretation depends on the PEth homologue measured, specimen type, analytical method, reporting threshold, collection history, serial results, and the purpose of testing.
PEth is used in clinical monitoring, transplant medicine, workplace and professional programs, family-law disputes, criminal matters, and other settings where a longer-window alcohol marker may be relevant. Its specificity for ethanol exposure makes it useful, but usefulness is not the same as unlimited interpretive power.
What PEth is
PEth refers to a group of abnormal phospholipids formed in blood when ethanol is present. Laboratories commonly measure PEth 16:0/18:1, sometimes with PEth 16:0/18:2, using liquid chromatography coupled with tandem mass spectrometry. Whole blood is the usual matrix because PEth is associated substantially with red blood cells. Dried blood spots may also be used under a validated procedure.
Because PEth formation requires ethanol, it is described as a direct alcohol biomarker. This differs from indirect markers such as gamma-glutamyl transferase, mean corpuscular volume, or carbohydrate-deficient transferrin, which can be affected by biological conditions other than alcohol exposure.
What question a PEth result can answer
| Question | What PEth may support | What PEth alone does not establish |
|---|---|---|
| Was there ethanol exposure? | A properly identified PEth result can support prior ethanol exposure. | The exact source, occasion, date, or number of drinks. |
| Was drinking recent? | PEth can remain detectable longer than ethanol itself and may reflect exposure over a period of weeks. | A precise drinking time or a reconstruction of blood alcohol concentration. |
| Was alcohol use heavy? | Higher or repeated results may be evaluated with validated decision limits and the full record. | A universal conversion from PEth concentration to drinks per day. |
| Was the person impaired? | PEth may provide context about prior exposure. | Impairment or functional condition at a specific event. |
| Was the person abstinent? | Serial results may help evaluate a monitoring period. | Absolute proof of abstinence without considering the assay, cutoff, timing, and specimen history. |
Why a result does not translate directly into drinks
People can produce and eliminate PEth at different rates. Relevant factors include the pattern and timing of alcohol exposure, the interval before collection, the starting concentration, individual biological variation, and the analytical procedure. A measurable value therefore cannot be converted reliably into one exact dose or date without unsupported assumptions.
A 2023 review of harmonized Swedish testing stated that a measurable PEth result confirms ethanol exposure, while interindividual variation in response and elimination prevents identification of the exact amount or time of intake. That distinction should remain visible whenever a laboratory number is used in a legal or administrative decision.
Decision limits require context
Some laboratories and programs use 20 ng/mL for PEth 16:0/18:1 as a decision point associated with beverage alcohol exposure. Other interpretive bands have been proposed for significant or heavy consumption. These numbers are not universal biological laws. The laboratory report, validated method, governing program, units, uncertainty, and scientific literature should be reviewed before applying a label.
A 2024 study of 30 participants reporting abstinence examined whether intensive incidental ethanol exposure could exceed 20 micrograms per liter, which is numerically equivalent to 20 ng/mL. Two results met or exceeded that level. The authors concluded that a result at or above the threshold supports a rebuttable presumption of beverage alcohol consumption while recognizing that unusual, intensive nonbeverage exposures may require investigation. One small study should not be stretched into a universal rule, but it illustrates why history and alternative explanations should be reviewed rather than ignored.
Specimen and analytical details matter
A useful laboratory review should identify:
- Whether the specimen was venous whole blood or a dried blood spot
- The PEth homologue or homologues reported
- The analytical method and identification criteria
- The limit of detection, limit of quantitation, and reporting threshold
- The calibration range and whether the result fell within that range
- Internal-standard and quality-control performance
- Collection, storage, transport, and specimen-integrity records
- Whether the laboratory participates in appropriate proficiency or external quality programs
Dried blood spot testing has practical advantages, but the method still requires validation for extraction, spot characteristics, internal standards, calibration material, stability, and instrument performance. A result from one matrix or procedure should not be assumed interchangeable with every other PEth method.
Single results and serial results answer different questions
A single result is a measurement at one collection time. Serial results can provide additional information about direction and pattern, but the timing between samples matters. A falling concentration can be consistent with elimination after prior exposure, while a rising concentration may be consistent with additional exposure. Neither pattern should be interpreted without considering analytical variation, the length of the interval, and the person's prior level.
When monitoring is the purpose, the protocol should define collection frequency, decision rules, handling of missed tests, and how results near a cutoff will be evaluated. Changing those rules after seeing a result can introduce bias.
PEth is not a test of impairment
PEth is not a substitute for a contemporaneous blood alcohol concentration, breath alcohol measurement, behavioral observation, or performance evidence. A PEth result obtained days or weeks after an event does not establish that alcohol was present in the person's blood at the event, much less that the person was impaired.
If impairment or causation is disputed, the analysis should separate four questions: whether ethanol exposure occurred, whether ethanol was present at the relevant time, whether functional impairment was present, and whether alcohol caused or contributed to the event. Different evidence is required for each question.
How PEth differs from EtG and EtS
Ethyl glucuronide and ethyl sulfate are also direct ethanol metabolites. They may be measured in urine, blood, or other matrices, depending on the procedure. Urinary EtG and EtS generally address a shorter period than blood PEth and can be influenced by urine concentration, collection timing, cutoff selection, microbial conditions, and incidental exposure issues.
The tests are complementary rather than interchangeable. The best marker depends on the question, time interval, matrix, and monitoring protocol. Comparing results requires attention to what each test was designed to establish.
Questions to ask when reviewing a PEth report
- What exact PEth homologue was measured, and in what specimen?
- What method, cutoff, units, and validated range did the laboratory use?
- Was the result qualitative, quantitative, or reported as a range?
- When was the specimen collected relative to the event or monitoring period?
- Are earlier or later PEth results available?
- Were collection, transport, storage, calibration, and quality-control records complete?
- What conclusion does the result support, and what conclusion is being added by inference?
- Have unusual exposure claims or specimen-specific issues been evaluated with evidence?
- Is anyone attempting to convert the result into an exact dose, date, or impairment opinion without adequate support?
Key interpretation principle
PEth is strong evidence when it is used to answer the question the method can address. It becomes weaker when a concentration is treated as a precise calendar, drink counter, or impairment test. The report should identify the analytical finding, the applicable decision framework, and the limits that remain.
Selected scientific sources
- Ulwelling W, Smith K. The PEth Blood Test in the Security Environment: What it is; Why it is Important; and Interpretative Guidelines. Journal of Forensic Sciences. 2018;63(6):1634-1640. doi:10.1111/1556-4029.13874.
- Helander A, et al. The alcohol biomarker phosphatidylethanol: recommendations for use and interpretation of test results. 2023. PMID: 37306004.
- Wagner M, et al. Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence. 2021. PMID: 33288956.
- Roache JD, et al. The effect of incidental ethanol exposures on the formation of blood phosphatidylethanol. Drug Testing and Analysis. 2024. doi:10.1002/dta.3752.
- SAMHSA. The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision.
For related scientific background, see Blood Alcohol Testing by GC-MS and FID, Dried Blood Spot Toxicology, and Toxicology Data Review.
Educational information only. Laboratory methods, reporting practices, and legal standards vary. Individual results require review in their specific scientific and factual context.